Accelerating Treatments to Patients (ATP)

The Accelerating Treatments to Patients (ATP) initiative is a comprehensive, integrated research and development program that represents the core of our work. ATP was launched in 2010 to speed up development of treatments which could slow or stop the progression of PKD. Each of the programs within ATP is important and interconnected.

 

Accelerating Treatments to Patients (ATP) Tissue Donation Grants Scientific Meetings Drug Repurposing Clinical Trial Awareness Program (CTAP) PKD Outcomes Consortium (PKDOC)

The PKD Foundation understands the urgency of finding a treatment for polycystic kidney disease. Patients have waited long enough – and that's why we're focusing on Accelerating Treatments to Patients (ATP), an initiative dedicated to finding a treatment as soon as possible.

 

Each program within ATP touches one of the following areas: new discoveries in basic PKD science, the development of potential clinical candidates, development of registration endpoints for clinical development, support of clinical trials and scientific meeting support.

 

Click or tap on a program to learn more about it.

 

Reset

 

ATP ChartDownload the ATP Overview infosheet


 

Your Organization

2000 Daniel Island Drive, Charleston SC 29492
Phone: 800.443.9441 | Fax: 843.216.6100
info@yourdomain.org

©2014, PKD Foundation ·The PKD Foundation is a 501 (c)(3), 509 (a)(1) public charity.

©2014, PKD Foundation ·The PKD Foundation is a 501 (c)(3), 509 (a)(1) public charity.